Gentrac Life Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 22-12-2024
- Paid Up Capital ₹ 2.00 M
as on 22-12-2024
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.00 M
as on 22-12-2024
- Revenue 47.71%
(FY 2022)
- Profit -404.91%
(FY 2022)
- Ebitda -4865.18%
(FY 2022)
- Net Worth -39.53%
(FY 2022)
- Total Assets -49.16%
(FY 2022)
About Gentrac Life Biotechnology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹9.00 M.
Manoher Malhotra, Prem Bansal, Sachin Malhotra, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100DL2013PTC254458
- Company No.
254458
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gentrac Life Biotechnology?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shikha Malhotra  | Director | 26-Jun-2013 | Current |
| Prem Bansal | Director | 26-Jun-2013 | Current |
| Manoher Malhotra | Director | 26-Jun-2013 | Current |
| Sachin Malhotra | Director | 26-Jun-2013 | Current |
Financial Performance of Gentrac Life Biotechnology.
Gentrac Life Biotechnology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.71% increase. The company also saw a substantial fall in profitability, with a 404.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 39.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gentrac Life Biotechnology?
In 2019, Gentrac Life Biotechnology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kois India Investment Advisors Private LimitedActive 7 years 9 monthsSachin Malhotra is a mutual person
Winqualis Consulting Private LimitedActive 4 years 29 daysManoher Malhotra and Sachin Malhotra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 22 Nov 2013 | ₹9.00 M | Open |
How Many Employees Work at Gentrac Life Biotechnology?
Unlock and access historical data on people associated with Gentrac Life Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gentrac Life Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gentrac Life Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
